Ledger.Open graph →
SEC Form D · filed July 15, 2009

Nile Therapeutics, Inc

Offering
$3.0M
Sold
$2.3M
Exemption
—
Industry
Pharmaceuticals
Location
San Francisco, CA
Type
—

People & firms on this filing (9)

David M. Tanen · San Francisco, CAExec · DirectorGregory W. Schafer · San Francisco, CADirectorDavid M. Tanen · New York, NYExec · DirectorPeter M. Kash · San Francisco, CADirectorPedro Granadillo · San Francisco, CADirectorJoshua A. Kazam · San Francisco, CAExec · DirectorPaul A. Mieyal, Ph.D · San Francisco, CADirectorGregory W. Schafer · Berkeley, CADirectorDaron Evans · San Francisco, CAExec

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗